This track focuses on the cellular and molecular pathways involved in neurodegenerative diseases, including the roles of apoptosis and autophagy. Participants will explore current research on disease models and potential therapeutic targets.

This session will delve into the phenylalanine hydroxylase (PAH) and trans-sulfuration pathways, examining their implications in neurological health. Researchers will present findings on how these pathways influence neurochemical balance and disease progression.

This track addresses the relationship between chronic stress and immune dysregulation in the brain, highlighting the neurochemical changes that occur. Discussions will include the impact of stress on neuroinflammatory responses and potential interventions.

Focusing on the cellular responses to traumatic brain injury, this session will cover the latest research on peripheral immune responses and neuroprotective strategies. Presentations will include innovative approaches to rehabilitation and recovery.

This track will explore the efficacy and mechanisms of antidepressant supplements in the management of mood disorders. Researchers will discuss the biochemical pathways influenced by these supplements and their clinical implications.

This session will investigate the peripheral neuroanatomy and the effects of sensory and sub-sensory level stimulation on neurological function. Presentations will focus on innovative stimulation techniques and their therapeutic applications.